Effect of SSRIs on Response to Psilocybin Therapy
Phase 2
Withdrawn
- Conditions
- Mild DepressionDepressionModerate DepressionMajor Depressive DisorderDepressive Disorder
- Interventions
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Cybin Therapeutics Inc.
- Registration Number
- NCT05594667
- Locations
- 🇨🇦
Centre for Neurology Studies x Upstream, Abbotsford, British Columbia, Canada
© Copyright 2025. All Rights Reserved by MedPath